NCT00849862View on ClinicalTrials.gov

Levetiracetam 750 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Healthy
Interventions
DRUG

Levetiracetam

750 mg Tablet

DRUG

Keppra®

750 mg Tablet

Trial Locations (1)

G1V 2K8

SFBC-Anapharm, Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00849862 - Levetiracetam 750 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter